- Infusion Pumps
- Metered Dose Inhalers
- Nebulizers
- Syringes
- Ocular Inserts
- Nasal Sprays
- Implantable Drug Delivery Devices
- Transdermal Patches
- Trans-Mucosal Drug Delivery Devices
- Others
Middle East and Africa Drug Delivery Devices Market size was valued at USD 102.47 Million in 2023 and is expected to reach USD 179.06 billion by 2030, at a CAGR of 7.7% from 2024-2030. Drug delivery devices are used to deliver drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevent various diseases such as diabetes, autoimmune disorders, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of the drug by controlling dosage, and time, and releasing the drug at specific sites in the body.
Middle East and Africa Drug Delivery Devices Market Dynamics
Drivers : Increase in the prevalence of chronic diseases such as diabetes and cancer. Expansion of business by market players. Rise in awareness about self-injector devices and development in economic growth Restraints : Stringent regulation for the approval of drug delivery devices. Product recalls and Complications in the use of drug delivery devices such as dosage errors. High cost of drug delivery devices
Middle East got significant share
Middle East and Africa Drug Delivery Devices Market
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Middle East And Africa Drug Delivery Devices Market Segmentation
By Product Type
By Route of Administration
- Oral
- Parenteral
- Transdermal
- Trans-Mucosal
- Inhalation
- Ocular
- Others
By Application
- Diabetes
- Oncology
- Autoimmune Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Respiratory Disorders
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Frequently Asked Questions
The Middle East and Africa Drug Delivery Devices Market size was valued at USD 102.47 million in 2023
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Middle East and Africa Drug Delivery Devices Market Introduction |
| 2.1.Middle East and Africa Drug Delivery Devices Market - Taxonomy |
| 2.2.Middle East and Africa Drug Delivery Devices Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2.Route of Administration |
| 2.2.3.Application |
| 2.2.4.Distribution Channel |
| 2.2.5.Country |
| 3. Middle East and Africa Drug Delivery Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East and Africa Drug Delivery Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East and Africa Drug Delivery Devices Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Infusion Pumps |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Metered Dose Inhalers |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nebulizers |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Syringes |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Ocular Inserts |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Nasal Sprays |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Implantable Drug Delivery Devices |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Transdermal Patches |
| 5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Trans-Mucosal Drug Delivery Devices |
| 5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6. Middle East and Africa Drug Delivery Devices Market By Route of Administration, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Transdermal |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Trans-Mucosal |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Inhalation |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Ocular |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Middle East and Africa Drug Delivery Devices Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Diabetes |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Oncology |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Autoimmune Disorders |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Neurological Disorders |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Gastrointestinal Disorders |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Respiratory Disorders |
| 7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8. Middle East and Africa Drug Delivery Devices Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Middle East and Africa Drug Delivery Devices Market By Country, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Middle East and Africa (MEA) |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. GCC Countries |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. South Africa |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Rest of MEA |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 10. Middle East and Africa (MEA) Middle East and Africa Drug Delivery Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Infusion Pumps |
| 10.1.2.Metered Dose Inhalers |
| 10.1.3.Nebulizers |
| 10.1.4.Syringes |
| 10.1.5.Ocular Inserts |
| 10.1.6.Nasal Sprays |
| 10.1.7.Implantable Drug Delivery Devices |
| 10.1.8.Transdermal Patches |
| 10.1.9.Trans-Mucosal Drug Delivery Devices |
| 10.1.10.Others |
| 10.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.2.3.Transdermal |
| 10.2.4.Trans-Mucosal |
| 10.2.5.Inhalation |
| 10.2.6.Ocular |
| 10.2.7.Others |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Diabetes |
| 10.3.2.Oncology |
| 10.3.3.Autoimmune Disorders |
| 10.3.4.Neurological Disorders |
| 10.3.5.Gastrointestinal Disorders |
| 10.3.6.Respiratory Disorders |
| 10.3.7.Others |
| 10.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospital Pharmacies |
| 10.4.2.Retail Pharmacies |
| 10.4.3.Online Pharmacies |
| 10.4.4.Others |
| 11. GCC Countries Middle East and Africa Drug Delivery Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Infusion Pumps |
| 11.1.2.Metered Dose Inhalers |
| 11.1.3.Nebulizers |
| 11.1.4.Syringes |
| 11.1.5.Ocular Inserts |
| 11.1.6.Nasal Sprays |
| 11.1.7.Implantable Drug Delivery Devices |
| 11.1.8.Transdermal Patches |
| 11.1.9.Trans-Mucosal Drug Delivery Devices |
| 11.1.10.Others |
| 11.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.2.3.Transdermal |
| 11.2.4.Trans-Mucosal |
| 11.2.5.Inhalation |
| 11.2.6.Ocular |
| 11.2.7.Others |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Diabetes |
| 11.3.2.Oncology |
| 11.3.3.Autoimmune Disorders |
| 11.3.4.Neurological Disorders |
| 11.3.5.Gastrointestinal Disorders |
| 11.3.6.Respiratory Disorders |
| 11.3.7.Others |
| 11.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospital Pharmacies |
| 11.4.2.Retail Pharmacies |
| 11.4.3.Online Pharmacies |
| 11.4.4.Others |
| 12. South Africa Middle East and Africa Drug Delivery Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Infusion Pumps |
| 12.1.2.Metered Dose Inhalers |
| 12.1.3.Nebulizers |
| 12.1.4.Syringes |
| 12.1.5.Ocular Inserts |
| 12.1.6.Nasal Sprays |
| 12.1.7.Implantable Drug Delivery Devices |
| 12.1.8.Transdermal Patches |
| 12.1.9.Trans-Mucosal Drug Delivery Devices |
| 12.1.10.Others |
| 12.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.2.3.Transdermal |
| 12.2.4.Trans-Mucosal |
| 12.2.5.Inhalation |
| 12.2.6.Ocular |
| 12.2.7.Others |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Diabetes |
| 12.3.2.Oncology |
| 12.3.3.Autoimmune Disorders |
| 12.3.4.Neurological Disorders |
| 12.3.5.Gastrointestinal Disorders |
| 12.3.6.Respiratory Disorders |
| 12.3.7.Others |
| 12.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospital Pharmacies |
| 12.4.2.Retail Pharmacies |
| 12.4.3.Online Pharmacies |
| 12.4.4.Others |
| 13. Rest of MEA Middle East and Africa Drug Delivery Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Infusion Pumps |
| 13.1.2.Metered Dose Inhalers |
| 13.1.3.Nebulizers |
| 13.1.4.Syringes |
| 13.1.5.Ocular Inserts |
| 13.1.6.Nasal Sprays |
| 13.1.7.Implantable Drug Delivery Devices |
| 13.1.8.Transdermal Patches |
| 13.1.9.Trans-Mucosal Drug Delivery Devices |
| 13.1.10.Others |
| 13.2. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.2.3.Transdermal |
| 13.2.4.Trans-Mucosal |
| 13.2.5.Inhalation |
| 13.2.6.Ocular |
| 13.2.7.Others |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Diabetes |
| 13.3.2.Oncology |
| 13.3.3.Autoimmune Disorders |
| 13.3.4.Neurological Disorders |
| 13.3.5.Gastrointestinal Disorders |
| 13.3.6.Respiratory Disorders |
| 13.3.7.Others |
| 13.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospital Pharmacies |
| 13.4.2.Retail Pharmacies |
| 13.4.3.Online Pharmacies |
| 13.4.4.Others |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Becton Dickinson and Company (U.S.) |
| 15.2.2.Hoffmann La Roche Ltd. (Switzerland) |
| 15.2.3.Smiths medical, Inc. (U.S.) |
| 15.2.4.Braun Melsungen AG (Germany) |
| 15.2.5.Pfizer, Inc. (U.S.) |
| 15.2.6.Merck & Co., Inc. (U.S.) |
| 15.2.7.Sanofi S.A. (France) |
| 15.2.8.Abbott Laboratories (U.S.) |
| 15.2.9.Novartis AG (Switzerland) |
| 15.2.10.Eli Lilly and company (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Becton Dickinson and Company (U.S.)
- Hoffmann La Roche Ltd. (Switzerland)
- Smiths medical, Inc. (U.S.)
- Braun Melsungen AG (Germany)
- Pfizer, Inc. (U.S.)
- Merck & Co., Inc. (U.S.)
- Sanofi S.A. (France)
- Abbott Laboratories (U.S.)
- Novartis AG (Switzerland)
- Eli Lilly and company (U.S.)